NCT07302776 2025-12-24TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCTStanford UniversityPhase 1 Not yet recruiting50 enrolled
NCT05088356 2025-12-19Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted GraftStanford UniversityPhase 1 Recruiting60 enrolled
NCT02129582 2021-05-07Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic MalignanciesCase Comprehensive Cancer CenterPhase 1 Completed14 enrolled
NCT01471067 2017-04-28Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic MalignanciesM.D. Anderson Cancer CenterPhase 1 Completed33 enrolled
NCT00402558 2015-05-08Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)M.D. Anderson Cancer CenterPhase 1 Completed15 enrolled